Profile picture

Doctor Erik Haakansson

Umea University Hospital, Umea (Sweden)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

Using dapagliflozin to reduce NT-proBNP and improve symptom in transthyretin cardiac amyloidosis - a series of n-of-1 trials pilot study
Presentation
Using dapagliflozin to reduce NT-proBNP and improve symptom in transthyretin cardiac amyloidosis - a series of n-of-1 trials pilot study
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources